Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 4, 2014, Pages 1562-1567

  Nešić, Dragana ^a   Buti, Ludovico ^b   Lu, Xin ^b   Stebbins, C Erec ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPP2 PROTEIN; CAGA PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ESCHERICHIA COLI; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; ION EXCHANGE CHROMATOGRAPHY; MUTAGENESIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ANTIGENS, BACTERIAL; APOPTOSIS REGULATORY PROTEINS; BACTERIAL PROTEINS; BINDING SITES; GENES, TUMOR SUPPRESSOR; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION;

EID: 84893399147     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320631111     Document Type: Article

References (55)

1. Peek RM, Jr., Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2(1):28-37.
2. Censini S, et al. (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93(25): 14648-14653.
3. Asahi M, et al. (2000) Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 191(4):593-602.
4. Backert S, et al. (2000) Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2(2):155-164.
5. Odenbreit S, et al. (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287(5457):1497-1500.
6. Stein M, Rappuoli R, Covacci A (2000) Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 97(3):1263-1268.
7. Covacci A, et al. (1993) Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90(12):5791-5795.
8. Tummuru MK, Cover TL, Blaser MJ (1993) Cloning and expression of a high-molecularmass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 61(5):1799-1809.
9. Hatakeyama M (2008) SagA of CagA in Helicobacter pylori pathogenesis. Curr Opin Microbiol 11(1):30-37.
10. Ohnishi N, et al. (2008) Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 105(3):1003-1008.
11. Franco AT, et al. (2008) Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 68(2):379-387.
12. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S (2002) Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 277(9):6775-6778.
13. Poppe M, Feller SM, Römer G, Wessler S (2007) Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 26(24):3462-3472.
14. Stein M, et al. (2002) c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 43(4):971-980.
15. Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4(9):688-694.
16. Higashi H, et al. (2005) EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem 280(24):23130-23137.
17. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR (2005) Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA 102(45):16339-16344.
18. Saadat I, et al. (2007) Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447(7142):330-333.
19. Nesic D, et al. (2010) Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat Struct Mol Biol 17(1):130-132.
20. Tsang YH, et al. (2010) Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene 29(41):5643-5650.
21. Buti L, et al. (2011) Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci USA 108(22):9238-9243.
22. Jiménez-Soto LF, et al. (2009) Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog 5(12):e1000684.
23. Lamb A, et al. (2009) Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep 10(11):1242-1249.
24. Hayashi T, et al. (2012) Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe 12(1):20-33.
25. Kaplan- Türköz B, et al. (2012) Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin. Proc Natl Acad Sci USA 109(36):14640-14645.
26. Knudson AG (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1(2): 157-162.
27. Katoh M (2007) Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 6(6):832-839.
28. Li QL, et al. (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109(1):113-124.
29. Samuels-Lev Y, et al. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8(4):781-794.
30. Sullivan A, Lu X (2007) ASPP: A new family of oncogenes and tumour suppressor genes. Br J Cancer 96(2):196-200.
31. Cong W, et al. (2010) ASPP2 regulates epithelial cell polarity through the PAR complex. Curr Biol 20(15):1408-1414.
32. Wang XD, et al. (2011) SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence. Cell Death Differ 18(2):304-314.
33. Wang Y, et al. (2012) Autophagic activity dictates the cellular response to oncogenic RAS. Proc Natl Acad Sci USA 109(33):13325-13330.
34. Sottocornola R, et al. (2010) ASPP2 binds Par-3 and controls the polarity and proliferation of neural progenitors during CNS development. Dev Cell 19(1):126-137.
35. Sgroi DC, et al. (1999) In vivo gene expression profile analysis of human breast cancer progression. Cancer Res 59(22):5656-5661.
36. Tordella L, et al. (2013) ASPP2 suppresses squamous cell carcinoma via RelA/p65- mediated repression of p63. Proc Natl Acad Sci USA 110(44):17969-17974.
37. Park SW, An CH, Kim SS, Yoo NJ, Lee SH (2010) Mutational analysis of ASPP1 and ASPP2 genes, a p53-related gene, in gastric and cololorectal cancers with microsatellite instability. Gut Liver 4(2):292-293.
38. Eftang LL, Esbensen Y, Tannæs TM, Bukholm IR, Bukholm G (2012) Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol 12:9.
39. Wroblewski LE, Peek RM, Jr., Wilson KT (2010) Helicobacter pylori and gastric cancer: Factors that modulate disease risk. Clin Microbiol Rev 23(4):713-739.
40. Blaser MJ, et al. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55(10):2111-2115.
41. Rotem S, Katz C, Friedler A (2007) Insights into the structure and protein-protein interactions of the pro-apoptotic protein ASPP2. Biochem Soc Trans 35(Pt 5):966-969.
42. Naumovski L, Cleary ML (1996) The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M. Mol Cell Biol 16(7):3884-3892.
43. Yang JP, et al. (1999) NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene 18(37):5177-5186.
44. Gorina S, Pavletich NP (1996) Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274(5289):1001-1005.
45. Rotem-Bamberger S, Katz C, Friedler A (2013) Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism. PLoS ONE 8(3): e58470.
46. Tan S, Noto JM, Romero-Gallo J, Peek RM, Jr., Amieva MR (2011) Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog 7(5):e1002050.
47. Tan S, Tompkins LS, Amieva MR (2009) Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog 5(5):e1000407.
48. Umehara S, Higashi H, Ohnishi N, Asaka M, Hatakeyama M (2003) Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene 22(51):8337-8342.
49. Oldani A, et al. (2009) Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog 5(10): e1000603.
50. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
51. Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr A 64(Pt 1):112-122.
52. Langer G, Cohen SX, Lamzin VS, Perrakis A (2008) Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc 3(7): 1171-1179.
53. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66(Pt 4):486-501.
54. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53(Pt 3): 240-255.
55. McNicholas S, Potterton E, Wilson KS, Noble ME (2011) Presenting your structures: The CCP4mg molecular-graphics software. Acta Crystallogr D Biol Crystallogr 67(Pt 4): 386-394.